期刊文献+

体外受精-胚胎移植中促性腺激素用药时间对妊娠结局的影响 被引量:9

Influence of duration of gonadotropin administration on the clinical outcome of in vitro fertilization embryo transfer
暂未订购
导出
摘要 目的:探讨在体外受精-胚胎移植(in vitro fertilization embryo transfer, IVF-ET)超促排卵中,促性腺激素(gonadotropin,Gn)用药时间对妊娠结局的影响。方法: 对2012年1~12月在北京大学第三医院生殖医学中心行IVF-ET助孕,促性腺激素释放激素激动剂(gonadotropin releasing hormone agonist,GnRH-a)短方案和促性腺激素释放激素拮抗剂(gonadotropin releasing hormone antagonist,GnRH-ant)方案的患者共3 221例进行回顾性分析。Gn用药时间小于等于7 d的患者为A组(n=58),Gn用药时间大于7 d为B组(n=3 163),比较两组患者年龄、不孕年限、体重指数、基础雌二醇(estradiol,E2)、促卵泡生成素(follicle-stimulating hormone,FSH)、窦卵泡数、获卵数、人绒毛膜促性腺激素(human chorionic gonadotropin,HCG)日子宫内膜厚度、受精率、优胚率、着床率及临床妊娠率等。结果:年龄、不孕年限、体重指数、基础E2、FSH、窦卵泡数两组间比较差异无统计学意义。A组获卵数少于B组[(8.2±5.6)vs.(12.1±8.3),P=0.009];HCG:日子宫内膜厚度A组小于B组[(9.9±2.1)mm vs.(10.4±1.6) mm,P=0.002]。两组间受精率、优胚率及着床率差异无统计学意义,临床妊娠率差异无统计学意义(36.2% vs. 33.6%,P〉 0.05)。A组中GnRH-a短方案18例,6例临床妊娠(33.3%),B组中GnRH-a短方案1 019例,277例临床妊娠(27.2%),临床妊娠率差异无统计学意义;A组中GnRH拮抗剂方案40例,15例临床妊娠(37.5%),B组中GnRH拮抗剂方案2 144例,785例临床妊娠(36.6%),临床妊娠率差异亦无统计学意义。结论:在IVF-ET中,应用GnRH-a短方案和GnRH拮抗剂方案Gn用药时间短的患者尽管获卵数较少,但最终妊娠结局未受到影响。 To investigate the influence of duration of gonadotropin (Gn) administration on the clinical outcome of in vitro fertilization embryo transfer (IVF-ET). Methods: A total of 3 221 cycles of short protocol or antagonist protocol in our center from January 2012 to December 2012 were included in the retrospective study. According to the different duration of Gn administration, all patients were divided into group A (≤7 days, n=58) and group B (〉7 days, n=3 163). The different clinical parameters, such as age, duration of infertility, body mass index (BMI), basis estradiol (E 2), folliclestimulating hormone (FSH), the number of antral follicle, the number of oocytes, endometrium thickness, fertility rate, good quality embryo rate, impatation rate and clinical pregnancy rate were compared between the two groups.Results: There was no significant difference in age, duration of infertility, BMI, basis E 2, FSH, the number of antral follicle between the two groups. The number of oocytes in group A was fewer than that in group B [(8.2±5.6)vs.(12.1±8.3),P=0.009]; endometrium thickness on the day of HCG in group A was thinner than that in group B [(9.9±2.1) mm vs.(10.4±1.6) mm,P=0.002]. There was no significant difference in fertility rate, good quality embryo rate, impatation rate and clinical pregnancy rate (36.2% vs. 33.6%, P〉 0.05). There was no significant difference in clinical pregnancy rate between the two groups in short protocol (33.3% vs. 27.2%, P〉 0.05). In the same way, there was no significant difference in clinical pregnancy rate between the two groups in antagonist protocol (37.5% vs. 36.6%, P〉 0.05). Conclusion: Although short duration of gonadotropin administration in short protocol and antagonist protocol has association with fewer number of oocytes, it may not affect the outcome of IVF- ET.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2013年第6期873-876,共4页 Journal of Peking University:Health Sciences
基金 "十二五"国家科技支撑计划(2012BAI32B01)项目 国家自然科学基金(81200413)资助~~
关键词 促性腺激素类 受精 体外 胚胎移植 妊娠率 Gonadotropins, Fertilization in vitro, Embryo transfer, Pregnancy rate
  • 相关文献

参考文献10

  • 1张丽珠.f临床生殖内分泌与不育症[M].2版.北京:科学出版社,2006:4-5.
  • 2Tarlatzis BC, Zepiridis L, Grimbizis G, et al. Clinical manage- ment of low ovarian response to stimulation for IVF: a systematic Review [J]. Hum Reprod Update, 2003, 9 (1) : 61 -76.
  • 3Ravhon A, LawrieH, Ellenbogen A, et al. A prospective, ran- domized controlled trial comparing the efficacy of recombinant folli- cle stimulation hormolne in three different in vitro fertilization pro- tocols [J]. Fertil Steril, 2000, 73 (5) : 908 -912.
  • 4Tarlatzis B, Kolibianakis E. GnRH agonists vs. antagonists [ J ]. Best Pract Res Clin Obst Gynaecol, 2007, 21 (1) : 57 -65.
  • 5A1-Ghamdi A, Coskun S, A1-Hassan S, et al. The correlation be- tween endometrial thickness and outcome of in vitro fertilization and embryo transfer (IVF-ET) outcome [ J ]. Reprod Biol Endo- crinol, 2008, 6 (2) : 37 -41.
  • 6Amir W, Micha B, Ariel H, et al. Predicting factors for endorne- trial thickness during treatment with assisted reproductive technolo- gy [J]. Fertil Steril, 2007, 87 (4) : 799 -804.
  • 7Bodri D, Sunkara SK, Coomarasamy A. Gonadotropin-releasing hormone agonists versus antagonists for controlXed ovarian hypers- timulation in oocyte donors: a systematic review and meta-analysis [J]. FertilSteril, 2011, 95 (1): 164-169.
  • 8Cota AM, Oliveira JB, Petersen CG, et al. GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morpholo- gY [J]. Reprod Biol Endocrinol, 2012, 10 (1) : 33.
  • 9Demirol A, Gurgan T. Comparison of microdose flare-up and an- tagonist multiple-dose protocols for poor-responder patients: a ran- domized study [ J ]. Fertil Steril, 2009, 92 (2) : 481 - 485.
  • 10Lainas TG, Sfontouris IA, Papanikolaou EG, et al. Flexible Gn- RH antagonist versus flare-up GnRH agonist protocol in poor re- sponders treated by IYF : a randomized controlled trial [ J ]. Hum Reprod, 2008, 23(6) : 1355 - 1358.

同被引文献73

  • 1刘颖,吴敬之.固胎汤降低体外受精-胚胎移植妊娠流产率127例临床研究[J].中医杂志,2006,47(4):272-273. 被引量:16
  • 2刘颖,吴敬之.Effect of Gutai Decoction (固胎汤) on the Abortion Rate of in vitro Fertilization and Embryo Transfer[J].Chinese Journal of Integrative Medicine,2006,12(3):189-193. 被引量:3
  • 3Kyrou D,Kolibianakis E M,Venetis C A,et al.How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization:a systematic review and meta-analysis[J].Fertil Steril,2009,91(45):749-766.
  • 4Revelli A,Casano S,Salvagno F,et al.Milder is better?Advantages and disadvantages of'mild'ovarian stimulation for human in vitro fertilization[J].Reprod Biol Endocrinol,2011,9(42):25.
  • 5Lamazou F,Fuchs F,Grynberg M,et al.Cancellation of IVFET cycles:poor prognosis,poor responder,or variability of the response to controlled ovarian hyperstimulation?An analysis of 142cancellations[J].Gynecol Obstet Biol Reprod,2012,41(12):41-47.
  • 6Demirtas E,Elizur E,Holzer H,et al.Immatare oocyte retrieval in the luteal phase to preserve fertility in cancer patieits[J].Reprod Biomed,2008,17(23):520-523.
  • 7Von Wolff M,Thaler Cj,Frambach T,et al.Random-srart controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles[J].Fertil Steril,2011,95(154):2125,e9-11.
  • 8Maman E,Meiron D,Brengauz M,et al.Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation[J].Fertil Steril,2011,95(65):64-67.
  • 9Ferraretti A P,Lamarca A,Fauser B C,et al.ESHRE consensus on the definition of'poor response'to ovarian stimulation for in vitro fertilization:the Bologna criteria[J].Ham Reprod,2011,26(63):1616-1624.
  • 10Zhen X M,Qiao J,Li R,et al.The clinical analysis of poor orarian response in-vitro-fertilization embryo-transfer among Chinese couples[J].J Assist Reprod uenet,2008,25(1):17-22.

引证文献9

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部